Skip to main content
ImmuneCited

Beschreibung

Mendelian randomization estimates illustrate the association between genetically predicted 25-hydroxyvitamin D levels and autoimmune disease risk. Genetic instruments derived from genome-wide association studies serve as proxies for long-term vitamin D exposure.

Figure 3

Forest Plot

Source Paper

Associations between vitamin D and autoimmune diseases: Mendelian randomization analysis.

Seminars in arthritis and rheumatism (2023)

PMID: 37437450

DOI: 10.1016/j.semarthrit.2023.152238

Cite This Figure

![Figure 3: Mendelian randomization estimates illustrate the association between genetically predicted 25-hydroxyvitamin D levels and autoimmune disease risk. Genetic instruments derived from genome-wide association studies serve as proxies for long-term vitamin D exposure.]()

> Source: Sizheng Steven Zhao et al. "Associations between vitamin D and autoimmune diseases: Mendelian randomization ." *Seminars in arthritis and rheumatism*, 2023. PMID: [37437450](https://pubmed.ncbi.nlm.nih.gov/37437450/)
<figure>
  <img src="" alt="Mendelian randomization estimates illustrate the association between genetically predicted 25-hydroxyvitamin D levels and autoimmune disease risk. Genetic instruments derived from genome-wide association studies serve as proxies for long-term vitamin D exposure." />
  <figcaption>Figure 3. Mendelian randomization estimates illustrate the association between genetically predicted 25-hydroxyvitamin D levels and autoimmune disease risk. Genetic instruments derived from genome-wide association studies serve as proxies for long-term vitamin D exposure.<br>  Source: Sizheng Steven Zhao et al. "Associations between vitamin D and autoimmune diseases: Mendelian randomization ." <em>Seminars in arthritis and rheumatism</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37437450/">37437450</a></figcaption>
</figure>